Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19

Oliveira, Jéssica Araujo da Paixão de; Athaide, Mariana Martins de; Rahman, Atta Ur; Barbosa, Mayara Garcia de Mattos; Jardim, Marcia Maria; Moraes, Milton Ozório; Pinheiro, Roberta Olmo.
Artículo en Inglés | ARCA | ID: arc-54594

Documentos relacionados

  1. Critical observation of WHO recommended multidrug therapy on the disease leprosy through mathematical study.
  2. Cyclosporin A as an Alternative Neuroimmune Strategy to Control Neurites and Recover Neuronal Tissues in Leprosy.
  3. Application of a physiotherapeutic protocol associated with photobiomodulation for the treatment of leprosy patients.
  4. Spatial distribution and temporal trends of tuberculosis case notifications, Uganda: a ten-year retrospective analysis (2013-2022).
  5. Mitochondrial variants of complex I genes associated with leprosy clinical subtypes.
  6. Elevated IL-23 in skin promotes IL-23 derived Th17 responses in leprosy patients.
  7. Epidemiological scenario of leprosy in marginalized communities of India: Focus on scheduled tribes.
  8. Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression.
  9. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
  10. CLINICAL PROGRESSION OF LEPROSY IN EURASIAN RED SQUIRRELS (<i>SCIURUS VULGARIS</i>) IN A NATURALLY INFECTED WILD POPULATION.